The crosstalk between C8orf76-mediated gene transcription and GSH metabolism may have broad implications for modulating HCC ferroptosis, suggesting that targeting the C8orf76/SLC7A11 pathway may improve anticancer therapy via ferroptosis induction. The gene discussed is SLC7A11; the disease is hepatocellular carcinoma.